Biomerieux analyzers maintenance procurement and warranty and maintenance and supplies for laboratory department for madigan army medical center.
Active Purchase Order Awarded Last action
- Contract number
- W81K0225PA074
- Awardee
-
Biomerieux Inc. UEI HCNVCMEG9NL6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $177,720
Award facts
- Opportunity
-
- Biomeriuex Sole Source Madigan Army Medical Center Special Notice · W81K0225QA109 · Posted Sep 22, 2025
- Contract value 32% obligated
-
- $377,979.56 Current, with exercised options
- $557,586.23 Potential, with all options
- Completion date 37% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- LEWIS MCCHORD, WA 98431, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Funding Only Action | $26,584 | |
| Supplemental Agreement for work within scope | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Funding Only Action | $151,136 | |
| Original award | $0 |
About this award
Defense Health Agency awarded a firm-fixed-price purchase order to Biomerieux Inc. on October 1, 2025, carrying a ceiling value of $557,586.23. The order used no set-aside. Medical Readiness Contracting Office - Pacific is the executing office under the Department of the Army Medical Command's originating notice. The order covers maintenance, warranty, reagents, and supplies for analyzer systems in the Department of Pathology at Madigan Army Medical Center, Lewis McChord, Washington 98431. Covered systems are VITEK2, VITEK MASS Spec, NuCLISENS EMAG, and BacT/Alert Virtuo analyzers. The award record shows performance from October 1, 2025 through September 30, 2028, and the description is tagged "OY 1." The originating Special Notice, posted September 22, 2025, announced intent to award sole source, classified the work under the In-Vitro Diagnostic Substance Manufacturing NAICS code and the Medical and Surgical Instruments PSC, and stated that no formal solicitation or Request for Quotes would be issued.
Quick answers
Who was awarded contract W81K0225PA074?
W81K0225PA074 was awarded to Biomerieux Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract W81K0225PA074 worth?
The government has obligated $177,720 on W81K0225PA074. Its current value, with exercised options, is $377,980. Its potential value, with all options, is $557,586.
Was contract W81K0225PA074 competed?
The extent of competition for W81K0225PA074 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award